FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - ValueSet, Realm US

13,139 resources

Type: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 11,158

 

Start Prev Rows 8600 - 8800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3381Observation Identifier (IIS)active2010-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.55Risk assessments relevant to pain managementactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.180Outpatient Prenatal Visitactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.182Eclampsiaactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.184Preexisting Hypertension in Pregnancyactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.185Postpartum Encounteractive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.186Postpartum Encounteractive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.187Postpartum Encounteractive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.189Spontaneous or Elective Abortionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.190Spontaneous or Elective Abortionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.191Preeclampsia or Eclampsiaactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.193Spontaneous or Elective Abortionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.179Hypertensive disorders in pregnancyactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.192Spontaneous or Elective Abortion Procedureactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.183Gestational Hypertensionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.188Preexisting Hypertension in Pregnancyactive2024-10hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFEItemRevenueVSPCT GFE NUBC Revenue Value Settrial-usefm2025-08hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFETypeOfBillVSPCT GFE NUBC Uniform Billing (UB-04) Type of Bill Value Settrial-usefm2025-08hl7
signal.core.r4R4ValueSet/provider-taxonomyProvider Taxonomy Codesdraftvocab2023-03hl7
fhir.cdc.opioid-cds-r4R4ValueSet/oncology-specialty-designationsOncology specialty designations (NUCC)active2023-05hl7
hl7.fhir.us.vdorR4ValueSet/vdor-gun-owner-codes-vsVDOR Coding Manual Gun Owner Codes Value Setinformativepher2025-06hl7
hl7.fhir.us.registry-protocolsR4ValueSet/NewYorkHeartAssociationAnswersNew York Heart Association OA Answer Listactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1021.121Federal Administrative Sexactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3043Lab Test Result Name (Hepatitis)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7954Medication Administered (Hansen)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7963Medication Administered (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7721Cruise Line (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7958Hospital Procedure (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7952Tribe Name (NND)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.292Non pharmacologic treatments for chronic pain NCIactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3279H1N1 Vaccine Manufactureractive2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3236National Reporting Jurisdictionactive2009-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.581PIM_Avandametactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.26Nonopioid pain medicationsactive2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.59DIRSectionTypeCodesactive2024-06hl7
fhir.org.nz.ig.baseR4ValueSet/coverage-typeCoverage Typeactive2025-06hl7
fhir.org.nz.ig.baseR4ValueSet/coverage-categoryCoverage Categoryactive2025-06hl7
fhir.org.nz.ig.baseR4ValueSet/iwiIwiactive2025-06hl7
fhir.giisR4ValueSet/NonVaccinationReasonVSNon vaccination reasondraft2025-07hl7
hl7.fhir.us.hsdsR4ValueSet/NonIndividualSpecialtiesNon-Individual Specialtiestrial-use2hss2023-10hl7
hl7.fhir.us.directory-queryR4ValueSet/NonIndividualSpecialtiesVSNon-Individual Specialtiesactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/NonIndividualSpecialtiesVSNon-Individual Specialtiestrial-usefm2025-02hl7
hl7.fhir.us.directory-queryR4ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates VStrial-usefm2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1046.279Triageactive2025-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/NonSustainedVentricularTachycardiaTypeNon-Sustained Ventricular Tachycardia Typeactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7279Non-Treponemal Test Result (STD)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.114NSAIDs Ingredients and Risk of GI Bleedingactive2023-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7142Non-Vertex Presentation (NCHS)active2014-01
hl7.fhir.us.mcodeR4ValueSet/mcode-normalization-basis-vsNormalization Basis Value Setactivecic2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.208Social Determinants of Health Screening Assessments Answersactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.207Social Determinants of Health Screening Assessments Questionsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.206Social Determinants of Health Screening Assessments And Questionsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.126Social Determinants of Health Screening Assessmentsactive2023-12hl7
hl7.fhir.us.breast-radiologyR4ValueSet/NotPreviouslySeenVSNotPreviouslySeen ValueSetactive2022-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.815Drugs of Abuse Screen in Urineactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.898Forearm X Rayactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.455Metabolic acidosis I10active2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.15Upon Death Preferencesactive2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3116Notifiable Condition (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1031Public Health Case Record Typeactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8058Nucleic Acid Viral Load Test Result (Hepatitis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3145Vaccine Doses Received (Pertussis)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3146Vaccine Doses Received (Tetanus)active2008-01
hl7.fhir.us.davinci-crdR4ValueSet/cmslocationcodesCMS Location Codes Value Settrial-use4fm2025-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1Selected non pharmaceutical therapies for moderate to severe chronic painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3selected muscle relaxants for pain controlactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3Selected topical agents for pain controlactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2selected non opioids for moderate to severe painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2Selected opioids for moderate to severe painactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1Selected urine drug screens for opioids indicating testing is completeactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2Selected urine screening for patients receiving opioid therapyactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1Opioids used for pain controlactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3selected first line medications for pain controlactive2015-08hl7
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1selected follow up visit intervals for opioid monitoringactive2015-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1019Diseases of Urinary Systemactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1301Surgery Integumentary System Breastactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1302Surgery Respiratory System Accessory Sinusesactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1303Surgery Respiratory System Larynxactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1304Surgery Respiratory System Trachea and Bronchiactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1305Surgery Respiratory System Lungs and Pleuraactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13064Surgery Digestive System Esophagusactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1307Surgery Digestive System Intestines (Except Rectum)active2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1308Surgery Digestive System Rectumactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1309Surgery Digestive System Anusactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1310Surgery Digestive System Biliary Tractactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1311Surgery Digestive System Abdomen Peritoneum Omentumactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1312Surgery Digestive System Kidneyactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13133Surgery Digestive System Ureteractive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1314Surgery Digestive System Bladderactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1315Surgery Female Genital System Cervix Uteriactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1316Surgery Female Genital System Corpus Uteriactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1317Surgery Female Genital System Oviduct Ovaryactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1318Surgery Eye and Ocular Adnexa Anterior Segmentactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13193Other Surgeriesactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13202SPECT MPIactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13213Stress Echocardiographyactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13222Stress MRIactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1323CCTAactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1329Diabetes Mellitusactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1330Renal insufficiencyactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1331Stroke transient ischemic attackactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1332Prior heart failureactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1333Ischemic heart diseaseactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1804Claim(s) for evaluation and management > 28 days and <60 days preceding the lumbar spine MRIactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.18143Patients with lumbar spine surgery in the 90 days prior to MRIactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1832Canceractive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1838Neoplastic abnormalitiesactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1839Treatment fields for radiation therapyactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1842Postoperative fluid collections and soft tissue changesactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1847Unspecified Immune Deficienciesactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1833Congenital spine and spinal cord malformationsactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1834Inflammatory and autoimmune disordersactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1835Infectious conditionsactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1836Spinal vascular malformations and/or the cause of occult subarachnoid hemorrhageactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1837Spinal cord infarctionactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1840Spinal abnormalities associated with scoliosisactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1841Syringohydromyeliaactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1844IV Drug Abuseactive2022-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1845Neurological Impairmentactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1846Human Immunodeficiency Virusactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1843Traumaactive2020-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1069Materialactive2010-01
signal.core.r4R4ValueSet/observation-categoryObservation Category Codesdraft1oo2019-10hl7
fhir.outburn.co.ilR4ValueSet/vs-observation-interpretationObservation Interpretationdrafthl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3357Observation Result Handling (HL7)active2010-01
hl7.fhir.us.vdorR4ValueSet/vdor-toxicology-summary-tests-vsVDOR Toxicology Summary Tests Value Setinformativepher2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.78Observation Interpretation (HL7)active2009-01
hl7.fhir.us.breast-radiologyR4ValueSet/ObservedChangesVSObservedChanges ValueSetactive2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.887Occupationactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1022Occupation Risk Category (TB)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1044Specimen Reject Reason (HL7)active2008-01
fhir.cdc.opioid-cds-r4R4ValueSet/synthetic-opioid-medicationsSynthetic opioid medicationsactive2023-05hl7
hl7.fhir.us.carin-bbR4ValueSet/OralBodySiteOral Body Site Value Settrial-usefm2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.923Order Control Code (HL7)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1027Previous Vaccine Historyactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7740Colony Count Magnitudeactive2018-01
hl7.fhir.us.haiR4ValueSet/nhsn-pathogen-rankingNHSNPathogenRankingactive2023-09hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7617Organism (FDD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7922Microorganism (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3266Microorganism (Pediatric Flu)active2009-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1237.13SNOMED Organism from LOINC Answer Listactive2024-01hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3062Transplant Organactive2010-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.8Vaccine Clinical Drugactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7489Transmission Mode (Arbovirus)active2016-01
fhir.giisR4ValueSet/OtherVaccineVSOther Vaccine codesdraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.959Additional Site of Disease (TB)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3094Other Related Casesactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8050Other Case Hepatitides (Hepatitis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3149Lab Test Method (VZ)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3071Pregnancy Outcome (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7798Pregnancy Outcome (Listeria)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.86Pregnancy Outcomeactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7680Fetal Outcome (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7981Animal Ownership (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3319Oxacillin Interpretation (IPD)active2010-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4436Gentamicin medicationsactive2024-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3294PHIN Questions (CRS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3295PHIN Questions (Malaria)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3298PHIN Questions (Rubella)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3299PHIN Questions (Strep Pneumo)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3050PHIN Questions (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3051PHIN Questions (ArboNet)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3052PHIN Questions (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3277PHIN Questions (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3276PHIN Questions (Flu Summary)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3053PHIN Questions (Generic)active2011-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1063PHIN Questions (Lead Case)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1065PHIN Questions (Lead Environmental)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1064PHIN Questions (Lead Laboratory Report)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3238PHIN Questions (Measles)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3237PHIN Questions (Mumps)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3278PHIN Questions (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3239PHIN Questions (Summary)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1061PHIN Questions (TB)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3054PHIN Questions (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1062PHIN Questions (Varicella)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/PCIOperatorPCI Operator SNOMED codesactivecic2023-11hl7
ca.on.dhdr.r4.v4R4ValueSet/encounter-participant-typeEncounter Participant Typeactive2019-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7552Organism Identified AST (STD)active2020-01
hl7.fhir.us.registry-protocolsR4ValueSet/PatientCenteredReasonforDelayPatient Centered Reason for Delayactivecic2023-11hl7
fhir.kenyaPSIGR4ValueSet/PatientContactRlshipVSPatient Contact Relationship ValueSetdraft2025-07hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTTaskAttachmentContentTypePCT Task Attachment Mime Typestrial-usefm2025-08hl7
fhir.kenyaPSIGR4ValueSet/PatientIdentifierTypesVSPatient Identifier Types ValueSetdraft2025-07hl7
fhir.giisR4ValueSet/AEFIPatientStatusVSPatient Status related to an AEFI codesdraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3404Patient Class (Syndromic Surveillance)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8051Patient Epidemiological Risk Factors (Hepatitis A)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8052Patient Epidemiological Risk Factors (Hepatitis B)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8053Patient Epidemiological Risk Factors (Hepatitis C)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8062Gender Identity (USCDI)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.756Gender Identityactive2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7610Gender Identity (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8063Sexual Orientation (USCDI)active2022-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7563Sexual Orientationactive2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7609Sexual Orientation (STD)active2018-01
fhir.kenyaPSIGR4ValueSet/PatientTitleVSPatient titledraft2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1060Abnormal Chest X-ray Condition Statusactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7713College Living Situation (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7678Discharge Location (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.994General Condition Statusactive2008-01